USFDA Looks for Ways to Speed up Plant Inspections

USFDA Looks for Ways to Speed up Plant Inspections The move has been triggered by the shortage of drugs — most of them supplied by Indian generic drug companies — that the US faces during the Covid-19 pandemic. The Indian Pharmaceutical Alliance has asked the FDA last month to find a solution for inspecting the manufacturing plants of its members. https://ift.tt/eA8V8J